BLPH NASDAQ
Bellerophon Therapeutics, Inc.
1W: +20.0%
1M: -68.4%
3M: -65.7%
1Y: -62.9%
3Y: -99.5%
5Y: -99.8%
$0.01
Last traded 2024-12-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$8M
-70.5% ▼
5Y CAGR: -26.4%
Total Liabilities
$5M
+2.8% ▲
5Y CAGR: -32.8%
Shareholders Equity
$3M
-88.3% ▼
Cash & Investments
$7M
-70.4% ▼
5Y CAGR: -25.4%
Total Debt
$203K
-78.7% ▼
Net Debt
-$7M
+71.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $17M | $10M | $48M | $25M | $7M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $405K |
| Cash & ST Investments | $17M | $10M | $48M | $25M | $7M |
| Net Receivables | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $101K | $103K | $103K | $103K | $234K |
| Total Current Assets | $17M | $10M | $48M | $25M | $8M |
| Property, Plant & Equip. | $664K | $2M | $2M | $930K | $186K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $300K | $300K | $0 | $300K | $0 |
| Other Non-Current Assets | $0 | $0 | $486K | $186K | $186K |
| Total Non-Current Assets | $964K | $3M | $2M | $1M | $372K |
| Total Assets | $18M | $13M | $50M | $27M | $8M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $3M | $4M | $1M | $1M |
| Short-Term Debt | $0 | $658K | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | -$658K | $0 | $0 | $0 |
| Total Current Liabilities | $8M | $8M | $10M | $5M | $5M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $7M | $274K | $601K | $1K | $0 |
| Total Non-Current Liabilities | $7M | $2M | $2M | $204K | $0 |
| Total Liabilities | $15M | $10M | $12M | $5M | $5M |
| — Equity — | |||||
| Common Stock | $587K | $46K | $95K | $95K | $96K |
| Retained Earnings | -$176M | -$190M | -$214M | -$232M | -$252M |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | $4M | $4M | $38M | $22M | $3M |
| Total Liabilities & Equity | $18M | $13M | $50M | $27M | $8M |
| — Key Metrics — | |||||
| Total Debt | $0 | $2M | $2M | $955K | $203K |
| Net Debt | -$17M | -$8M | -$46M | -$24M | -$7M |
| Total Investments | $300K | $300K | $0 | $300K | $405K |